Cardiovascular Disease

The Practical Cardiology™ Cardiovascular Disease clinical resource center hosts content related to a wide array of cardiovascular conditions. The leading cause of death in the United States, the term cardiovascular disease encompasses a multitude of conditions and this page serves as a hub for information to several of the most common conditions, including atherosclerotic cardiovascular disease, acute coronary syndromes, hypertension, and more.

CLARIFY: Diabetes Poses Major Risk in Patients with Coronary Syndromes

April 13, 2021

An analysis of the CLARIFY registry is providing clinicians with further insight into the impact of diabetes in patients with chronic coronary syndromes, particularly the increased risk of stroke, myocardial infarction, and cardiovascular death.

Case Report: Altered College Student

April 12, 2021

Our latest case report from Dr. Brady Pregerson features a 20 y/o female brought to the emergency department by EMS for altered mental status. Check out the EKG and see if you can determine the diagnosis.

Transition to Telemedicine Practices May Have Streamlined Care in Cardiology Clinics

April 07, 2021

An analysis of data from Cedars-Sinai medical centers suggests the shift to telemedicine during the pandemic led to a reduction in a number of diagnostic tests and medications prescribed when compared to rates of both during the pre-pandemic era.

Study Calls for Change in Prescribing Practices of Antihypertensive Agents in Patients with HIV

April 06, 2021

An analysis of more than 8000 patients with HIV and hypertension suggests these patients may not be receiving the most efficacious antihypertensive agents and this could be placing these patients at increased risk of cardiovascular disease events or death.

Rosuvastatin/Ezetimibe Combination Therapy Approved for Lowering LDL-C

April 05, 2021

Althera Pharmaceuticals announced the FDA approved rosuvastatin and ezetimibe (Roszet) as an adjunct to diet for lowering LDL-C in adults patients with primary non-familial hyperlipidemia or homozygous familial hypercholesterolemia.

Psychosocial Stress Linked to Heart Attacks in Men

April 04, 2021

A study from the ESC Acute CardioVascular Care 2021 Online Congress is providing clinicians with further insight into the effects of psychosocial stress on the cardiovascular health of men.

Sotatercept Reduces Pulmonary Vascular Resistance in Patients with Pulmonary Arterial Hypertension

April 01, 2021

Results of the phase 2 PULSAR trial indicate sotatercept could be an effective adjunct to background medical therapy for reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension.

Inflammatory Diseases Double Mortality Risk in Young Heart Attack Patients

March 31, 2021

An analysis of the YOUNG-MI registry suggests patients aged 50 or younger who suffer a heart attack were at nearly twice the risk of mortality if they had a diagnosis of a systemic inflammatory disease, such as rheumatoid arthritis and lupus, when compared to their counterparts without an inflammatory disease.

Gender Disparities in Acute Myocardial Infarction

March 30, 2021

Dr. Gregory Weiss, a critical care cardiologist, offers perspective on a study examining disparities in the diagnosis and treatment of women who experience acute myocardial infarction.

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk in Women with Nisha Parikh, MD

March 29, 2021

The American Heart Association is highlighting the effect of adverse pregnancy outcomes on risk of cardiovascular disease later in life among women. Check out this interview with the chair of the writing committee for more perspective on the statement.